Teva Pharmaceutical Industries - M&A Summary and Business Overview

Life ScienceCompany

Teva Pharmaceutical Industries M&A Summary

Teva Pharmaceutical Industries has acquired 23 companies. A total of 3 acquisitions came from private equity firms. It has also divested 9 assets.

Teva Pharmaceutical Industries’ largest acquisition to date was in 2015, when it acquired Allergan Generics for $40.5B. It’s largest disclosed sale occurred in 2017, when it sold Teva Pharmaceutical Industries - PARAGARD to CooperSurgical for $1.1B. Teva Pharmaceutical Industries has acquired in 7 different US states, and 8 countries. The Company’s most targeted sectors include life science (87%) and distribution (5%).

Teva Pharmaceutical Industries Business Overview

Where is Teva Pharmaceutical Industries headquartered?

Teva Pharmaceutical Industries is headquartered in Tel Aviv, Israel.

What is Teva Pharmaceutical Industries’ revenue?

Teva Pharmaceutical Industries disclosed revenue of 14,925M USD for 2022 and 15,879M USD for 2021.

How many employees does Teva Pharmaceutical Industries have?

Teva Pharmaceutical Industries has 34,004 employees.

What sector is Teva Pharmaceutical Industries in?

Teva Pharmaceutical Industries is a life science company.

When was Teva Pharmaceutical Industries founded?

Teva Pharmaceutical Industries was founded in 1901.

M&A Summary

  • M&A Total Activity32
    • M&A Buy Activity23
    • M&A Sell Activity9
  • Total Sectors Invested 4
  • Total Countries Invested 8
  • M&A Buy/Sell Connections 14
  • M&A Advisors 12

Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Ltd.

124 Dvora Hanevi’a Street,
Tel Aviv, 6944020
Israel,
+972 3 914 8213
www.tevapharm.com

Teva Pharmaceutical Industries is a provider of pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Teva Pharmaceutical Industries was founded in 1901 and is based in Tel Aviv, Israel.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 23 - - - - - 23
vol $76.7B $76.7B
Sell (0.4/yr) # 7 - 2 - - - 9
vol $3.1B $3.1B
  32

Most Recent M&A

Company Date Value Type
Immuneering Corp. 2021-07-29 - IPO
Cambridge, Massachusetts · www.immuneering.com
Zdravlje AD 2021-04-01 - Divestiture
Leskovac, Serbia · www.zdravlje.co.rs
Theramex HQ UK Ltd. 2018-02-01 703M USD Divestiture
London, United Kingdom · www.thermamex.com
Plan B One-Step 2017-09-18 675M USD Divestiture
Petach Tikva, Israel
Teva Pharmaceutical Industries Ltd. - PARAGARD 2017-09-11 1.1B USD Divestiture
Buffalo, New York
Anda, Inc. 2016-08-02 500M USD Divestiture
Parsippany, New Jersey · www.andanet.com
Teva Pharmaceutical Industries Ltd. - Generic Products 2016-06-21 586M USD Divestiture
Petach Tikva, Israel
Representaciones e Investigaciones Medicas S.A. de C.V.(Rimsa) 2015-10-01 2.3B USD Add-on Acquisition
Mexico City, Mexico · www.gruporimsa.com
Gecko Health Innovations, Inc. 2015-09-25 - Add-on Acquisition
Cambridge, Massachusetts · www.caretrx.com
Immuneering Corp. 2015-08-03 - Add-on Acquisition
Cambridge, Massachusetts · www.immuneering.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 20 (87%) 68.7B (90%) 8 (89%) 2.0B (65%)
Medical Products 1 (4%) 7.5B (10%) 1 (11%) 1.1B (35%)
Distribution 1 (4%) 500M (1%) - -
Internet Software and Services 1 (4%) - - -
Total 23 $76.7B 9 $3.1B

By Geo

State/Country Buy Value Sell Value
United States 15 70.0B 3 1.1B
  California 4 47.3B - -
  Massachusetts 3 - 1 -
  New Jersey 3 8.0B - -
  Pennsylvania 2 6.9B - -
  New Hampshire 1 360M - -
  Maryland 1 - - -
  Florida 1 7.4B - -
  New York - - 1 1.1B
Israel - - 4 1.3B
Germany 2 4.1B - -
United Kingdom 1 299M 1 703M
Canada 1 - - -
  Ontario 1 - - -
Croatia 1 - - -
Italy 1 - - -
Mexico 1 2.3B - -
Peru 1 - - -
Serbia - - 1 -
Domestic - - 4 (44%) 1.3B (42%)
Cross-border 23 (100%) 76.7B (100%) 5 (56%) 1.8B (58%)
Total 23 $76.7B 9 $3.1B

Top M&A Advisors

Financial Deals
Credit Suisse Investment Banking
3
Goldman Sachs
2
Lehman Brothers, Inc.
2
Legal Deals
Kirkland & Ellis
3
Goodwin Procter
2
Agmon with Tulchinsky Law Firm
1

Deal Values

buy # Total
> $1B 8 $75.1B
$100M to $1B 5 $1.5B
< $100M 1 $40M
TOTAL $76.7B
Largest Allergan Generics
$40.5B (2015-07-27)
sell # Total
> $1B 1 $1.1B
$100M to $1B 3 $2.0B
< $100M 2 $49M
TOTAL $3.1B
Largest Teva Pharmaceutical Industries Ltd. - PARAGARD
$1.1B (2017-09-11)

M&A Connections

Deals
Acquired from
Investor(s)
13%
3 (13%)
Strategic(s)
17%
4 (17%)
Divested to
Investor(s)
11%
1 (11%)
Strategic(s)
78%
7 (78%)

 Subscribe to unlock this and 203,076
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 199K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Teva Pharmaceutical Industries

Life Science Companies , Israel Companies